Wall Street is positive on United Therapeutics Corporation (UTHR). On average, analysts give UTHR a Strong Buy rating. The average price target is $235, which means analysts expect the stock to climb by 19.70% over the next twelve months. That average ranking earns UTHR an Analyst Rating of 63, which is better than 63% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating UTHR a Strong Buy today. Find out what this means to you and get the rest of the rankings on UTHR!